DGAP-News: 'New Balda' wins orders from prominent customers


DGAP-News: Balda AG / Key word(s): Incoming Orders
'New Balda' wins orders from prominent customers

10.07.2013 / 10:38

---------------------------------------------------------------------



  - Supply agreement with premium-segment US audio company expanded thanks
    to innovative Balda technology

  - Initial project inquiries from German medical customers for production
    in the United States

  - Another international medical customer acquired

  - Consolidated sales target for 2013/2014: EUR 85 to 90 million

Bad Oeynhausen, 10 July 2013 - The Balda Group, a provider of high-quality
plastics solutions, today announced that following its strategic
repositioning it has won orders from prominent customers. In the Balda
Technical segment, for instance, the partnership with a premium-segment US
audio company was expanded considerably. In addition, an innovative
manufacturing technology is being used for the first time in production at
the Anaheim, California, plant thanks to technology transfer from Germany
to the United States. This involves integrating the surface decoration
directly into the production process to create a high-quality feel for the
product.

The Balda Medical segment is also increasingly benefiting from the
strategic opportunities provided by the acquisition at the end of 2012 of
US-based plastics companies Balda C. Brewer and Balda HK Plastics. Balda
Medical has received its first requests from Balda customers in Europe who
wish to manufacture in the United States. The United States is the world's
largest market for medical technology products. Balda has medical
production facilities abroad in Anaheim, Ontario and Oceanside, all located
in California in a 'medical valley.'

Balda Medical has also attracted another international customer with
headquarters in Germany. Balda will manufacture cuvettes for this prominent
manufacturer of medical technology equipment.

Based on the current order situation and the Group's current portfolio,
i.e. excluding any further acquisitions, the Management Board expects to
report consolidated sales of between EUR 85 and 90 million and an EBITDA
margin (EBITDA as a percentage of sales) in the high single-digit range for
the 2013/2014 financial year (reporting date: 30 June). Both operating
segments are expected to meet the target EBITDA margin of 15% before
intra-Group charges.

Dominik Müser, Chief Executive Officer of Balda AG: 'The new Balda is an
increasingly attractive partner for global customers in the United States
as well as Europe. It is becoming more and more apparent that the
acquisitions in the United States at the end of 2012 were the right step.
Both US-based companies have contributed positively to Group profit since
their initial consolidation on 1 January 2013. In financial year 2013/2014,
which has just begun, they will again contribute substantially to our
planned revenue growth and to reinforcing the positive earnings performance
of the Balda Group.'

Contact:
Frank Elsner 
Frank Elsner Kommunikation für Unternehmen GmbH
Tel.: +49 - 54 04 - 91 92 0
Fax: +49 - 54 04 - 91 92 29
Mail: office@elsner-kommunikation.de

About Balda 
Balda is a provider of first-class solutions for demanding, high-quality
applications in the fields of medical technology, optics, the automotive
industry and other specialist industrial sectors. The Group's Balda Medical
and Balda Technical operating divisions have operations worldwide, and the
company maintains production facilities in Germany and the USA. The success
of Balda, which employs around 1,000 people, is based on the deployment of
leading-edge, cost-effective technologies, coupled with the trust-based
collaboration with customers. The Balda AG share (ISIN: DE0005215107) is
listed on the SDAX segment of Deutsche Börse. The Group's financial year
ends on 30 June.
www.balda-group.com
www.balda-medical-group.com


End of Corporate News

---------------------------------------------------------------------

10.07.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                
Company:     Balda AG                                               
             Bergkirchener Str. 228                                 
             32549 Bad Oeynhausen                                   
             Germany                                                
Phone:       +49 (0) 57 34 / 9 22-0                                 
Fax:         +49 (0) 57 34 / 9 22-2604                              
E-mail:      info@Balda.de                                          
Internet:    www.balda.de                                           
ISIN:        DE0005215107                                           
WKN:         521510                                                 
Listed:      Regulierter Markt in Frankfurt (Prime Standard);       
             Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,  
             München, Stuttgart                                     
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
220580 10.07.2013